TABLE 1.
Characteristic | Valuea |
---|---|
No. (%) male patients | 34 (60.7) |
Mean (SD) age (yr) | 60.9 (19.8) |
Mean (SD) wt (kg) | 81.2 (21.4) |
Race | |
Caucasian | 44 (78.6) |
Hispanic | 7 (12.5) |
Other | 5 (8.9) |
Mean (SD)APACHE II score | 13.8 (7.0) |
Mean (SD) CLCR (ml/min) | 99.4 (53.9) |
No. (%) of patients with infection at the following site: | |
Respiratory | 37 (66.1) |
Skin and skin structure | 14 (25.0) |
Bacteremia | 5 (8.9) |
Mean (SD) Charlson comorbidity score | 3.8 (3.6) |
No. (%) of patients with the following comorbidities: | |
Diabetes | 18 (32.1) |
Cardiovascular disease | 22 (39.3) |
Chronic renal failure | 11 (19.6) |
Immunosuppression | 4 (7.1) |
No. (%) of patients receiving the following cefepime regimen: | |
1 g every 24 h | 2 (3.6) |
1 g every 12 h | 28 (50) |
1 g every 8 h | 12 (21.4) |
2 g every 12 h | 2 (3.6) |
2 g every 8 h | 4 (7.1) |
2 g every 8 h (3-h infusion) | 8 (14.3) |
Data are for 56 patients.